Product information

From Health Canada

Note - The product information found within this database originates from organizations not subject to the Official Languages Act and is available in the language in which it was written and submitted to Health Canada.

Note - The market status of a product is now available in the LNHPD and identifies if a product is "marketed" or "not marketed" in Canada. Product licence holders may voluntarily provide the Natural and Non-Prescription Health Products Directorate (NNHPD) with information about whether their product is currently available to Canadian consumers. Where no information has been provided, the default status is "not marketed". The "current status" field remains unaffected and will continue to indicate the status of the product licence (i.e., active, discontinued, stop sale, cancelled, or suspended). Note that where a licence has been suspended, cancelled or under stop sale, the product cannot be legally sold in Canada.

Product licence holders - if you wish to update a product's market status, you are invited to complete the Natural Health Products Market Notification Web Form. As with all other notifications, there is no current service standard. The NNHPD will process the market status update as soon as feasible, based on its available resources. As a reminder, market notification is voluntary; therefore, a licence holder is not required to wait for the LNHPD to be updated before a licensed product is sold in Canada. As such, products that are identified in the LNHPD as "not marketed" may still be sold in Canada.

New search

Natural Product Number (NPN):
80027780
Market status:
Marketed
Licence Status:
Active
Brand name(s):
Red Clover Isoflavones
Licence holder:
New Roots Herbal Inc.
Dosage Form:
Capsule
Recommended route of administration:

Oral

Recommended dose:
Sub population (Sub Pop.) Quantity (Qty) Frequency (Freq.)
Sub Pop. Age Min. Max. UoM Footnote1 Age Qty Min. Max. UoM Qty Freq. Min. Max. UoM Freq.
Women (post-menopausal) 3.0 capsule 1 daily
Recommended use or purpose:
Red clover isoflavones improve symptoms associated with menopause; Attenuates lumbar Bone Mineral Density loss with adequate intake of Calcium and Vitamin D in post-menopausal women.
Risk Information:
Cautions and Warnings 
Consult a health care practitioner prior to use if you are taking hormone replacement therapy, oral contraceptives, or anticoagulants. Consult a health care practitioner prior to use if you are taking thyroid hormone therapy. Consult a health care practitioner prior to us if you have a liver disorder or develop liver-related symptoms (eg. abdominal pain, jaundice, dark urine). Do not use if you currently or previously have had breast cancer or if you have a predisposition to breast cancer such as abnormal mammogram and/or biopsy, or family member with breast cancer. Consult a health care practitioner prior to use if you have a personal history of hormonal or gynaecological disease including ovarian cancer, endometriosis and/or uterine fibroids. Before use, be sure you are up-to-date on appointed clinical tests such as mammograms and endometrial ultrasounds/biopsies. Discontinue use and consult a health care practitioner if you experience breast pain, discomfort, soreness and/or tenderness, abnormal uterine bleeding including spotting and/or recurrence of menstruation in postmenopausal women.
Contra-Indications 
Do not take if you are pregnant or breastfeeding.
List of medicinal ingredients:
Medicinal ingredients Quantity (Qty) Extract Potency
Trifolium pratense 60.0 mg
40.0   %
Isoflavones
20.16   mg AIE
Trifolium pratense 360.0 mg
List of non-medicinal ingredients:
  • Hypromellose
  • Magnesium Stearate
  • Purified water
  • Silicon dioxide
Date of licensing:
2011-10-25
Revised date of licence:
2012-03-09

Application information

Related information

Compendium of monographs

Contact us

For technical support or if you have general questions concerning the content of this database, please contact the Natural Health Products Directorate (NHPD).

Date modified: